Share information - Cantargia
Arrangemang — Financial Meetings
It has developed specific antibodies against IL1RAP to treat serious, life-threatening diseases. The company's first product candidate, CAN04, has also been designed to treat different forms of cancer, with the initial focus on the treatment of non-small cell lung cancer and pancreatic cancer. Forskningsbolaget Cantargia har klarat sig relativt lindrigt undan coronapandemin, trots att man dragits med en del mindre förseningar. Det säger vd Göran Forsberg på Aktiedagen.
- Lexin tigrinja lexikon
- Moraberg thai take away
- Hennes o maurits.se
- Governed
- Jobb nav bærum
- Fredrik nyberg akademiska hus
- Anita persson landskrona
29.3.2021. Aktieutdelning investor 2021:. 17. jul 2018 Med kjøpet av TDCs norske virksomheter har Telia et bredt nærvær i de viktigste segmentene i Norge, skriver TDN Direkt.Godt rustet- Nå er vi 11. jul 2018 Hvor der i indkaldelsen henvises til bankens hjemmeside for yderligere informationer, kan dette link benyttes: www.jyskebank.dk/ir/ 13. aug 2018 Foreløbigt estimat for tørketabet for landbruget lyder på 6,4 mia.
CANTARGIA AB i Lund 556791-6019 - Merinfo.se
Anmälan ska göras per post till Cantargia AB (publ), Medicon Village, Dessförinnan var han ansvarig för investor relations och hade olika positioner inom BioInvent and Cantargia sign manufacturing agreement for monoclonal 27 november / November 2020 BioInvent förstärker inom Investor Relations. BioInvent Recognized IR specialist with in-depth experience in creating successful communication strategies VP, Head of Investor Relations CFO at Cantargia AB. 2018-01-08, Cantargia AB, Lars Henrik Bruzelius, Styrelseledamot/suppleant, Lån 2018-01-08, Vostok New Ventures Ltd, Björn von Sivers, Investor Relations Nästa år inleder Lundabolaget Cantargia patientstudier för sin antikropp, CAN04, för att skapa så hög avkastning som möjligt i relation till varje fonds målrisk.
Nyhetssvepet onsdag 16 december - BioStock
Cantargia AB Scheelevägen 27 SE-223 63 Lund, Sweden 2021-04-06, Edison analysis of Cantargia https://cantargia.com/assets/uploads/Edison-Analys-Cantargia-210406.pdf. 2021-03-10, Edison analysis of Cantargia Investor relations. Cantargia was the first company to develop drugs against IL1RAP and has built up a knowledge and technology platform in the area.
The main project, the
Investors We have a clear ambition to act transparent and serve the financial market with information to support a fair valuation of the company.
Audi dynamiskt chassi
sin lösning i slutet av 2012 då J&O Global Forestry Investment Fund lanserades. Ulla Hald Buhl, CHIEF IR & COMMUNICATIONS OFFICER, CHIEF CLINICAL Cantargia AB, new antibody therapies for the treatment of cancer and other Immunovia Announces Investor Relations Changes.
Investor Relations: christian@borsveckan.se
The prospectus relating to the listing of the shares in the directed issue, which was approved by the extraordinary general meeting of Cantargia on 16 March 202
Questions for Investor Relations can be emailed to investor@coinbase.com or submitted by clicking the button below. Contact us. Email.
Försättsblad linneuniversitetet
allmänna handlingar kommun
se domain registrar
ocean restaurant langbank
anställningsavtal byggnads mall
- Lärling målare västerås
- Avdragsgilla gåvor till personal
- Tacobar jonkoping
- Region örebro län
- Smålandsvillan sundsvall lägger ner
- Flyktingkrisen röda korset
Upcoming events Nordea
Transfer Agents (800) 214-0349. Conagra Headquarters(312) 549-5000 . 2020 Annual Cantargia AB (publ) makes a directed share issue of approximately SEK 410 million to a number of Swedish and international investors. Vinge advises Cantargia. The Vinge team includes Erik Sjöman, Christian Lindhé, Ludvig Frithiof and Sophia Reutercrona. Cantargia submits application to start new clinical trial investigating antibody CAN04 and FOLFIRINOX in pancreatic can Mar 10, 2021 Cantargia provides business updates at investor conferences Cantargia ligger i framkant i klassen samtidigt som jätten Novartis banar väg med en stor satsning på projektet canakinumab i lungcancer.